Long-term follow-up of Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year period [8]

British Journal of Haematology

Volumn 130, Issue 6, 2005, Pages 970-972

  Giona, Fiorina ^a   Moleti, Maria Luisa ^a   Del Giudice, Ilaria ^a   Testi, Anna Maria ^a   Diverio, Daniela ^a   De Cuia, Maria Rosaria ^a   Mandelli, Franco ^a   Foà, Robin ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

interferon; Allogeneic stem cell transplant; Children; Long term survival; Ph+ chronic myeloid leukaemia

Indexed keywords

IMATINIB; INTERFERON; ALPHA INTERFERON; ANTINEOPLASTIC AGENT;

ADOLESCENT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CHILD; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CONFIDENCE INTERVAL; DOSE RESPONSE; HUMAN; LETTER; LONG TERM CARE; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SURVIVAL; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; MYELOID LEUKEMIA;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE;

EID: 27244448702     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05731.x     Document Type: Letter

References (6)

1. Champagne M.A. Capdeville R. Krailo M. Qu W. Peng B. Rosamilia M. Therrien M. Zoellner U. Blaney M.S. Bernstein M. ( 2004) Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome positive leukemia: results from a Children's Oncology Group phase I study. Blood, 104, 2655 2660.
2. Dow L.W. Raimondi S.C. Culbert S.J. Ochs J. Kennedy W. Pinkel D.P. ( 1991) Response to alpha-interferon in children with Philadelphia chromosome-positive chronic myelocytic leukemia. Cancer, 68, 1678 1684.
3. Kantarjian H.M. Cortes J.E. O'Brien S.G. Luthra R. Giles F. Verstovsek S. Faderl S. Thomas D. Garcia-Manero G. Rios B.M. Shan J. Jones D. Talpaz M. ( 2004) Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukaemia failure of interferon-alpha. Blood, 104, 1979 1988.
4. Millot F. Brice P. Philippe N. Thyss A. Demeoq F. Wetterwald M. Boccara J.F. Vilque J.P. Guyotat D. Guilhot J. Guilhot F. ( 2002) Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia. Journal of Pediatric Hematology Oncology, 24, 18 22.
5. O'Brien S.G. Guilhot F. Larson R.A. Gathmann I. Baccarani M. Cervantes F. Cornelissen J.J. Fischer T. Hochhaus A. Hughes T. Lechner K. Nielsen J.L. Rousselot P. Reiffers J. Saglio G. Shepherd J. Simonsson B. Gratwhol A. Goldman J.M. Kantarjan H. Taylor K. Verhoef G. Bolton A.E. Capdeville R. Drucker B.J. ( 2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed cronic-phase myeloid leukemia. New England Journal of Medicine, 348, 994 1004.
6. Steegmann J.L. Casado L.F. Tomas J.F. Sanz-Rodriguez C. Granados E. de la Camara R. Alegre A. Vazquez L. Ferro M.T. Figuera A. Arranz R. Fernandez-Ranada J.M. ( 1999) Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant, 23, 483 488.